TY  -  
T1  - Antithrombotic therapy use and clinical outcomes following thrombo-embolic events in patients with atrial fibrillation : insights from ARISTOTLE 
SN  -  /  
UR  - http://hdl.handle.net/10138/299450 
T3  -  
A1  - Goto, Shinya; Merrill, Peter; Wallentin, Lars; Wojdyla, Daniel M.; Hanna, Michael; Avezum, Alvaro; Easton, J. Donald; Harjola, Veli-Pekka; Huber, Kurt; Lewis, Basil S.; Parkhomenko, Alexander; Zhu, Jun; Granger, Christopher B.; Lopes, Renato D.; Alexander, John H. 
A2  -  
PB  -  
Y1  - 2018 
LA  - eng 
AB  - Aims We investigated baseline characteristics, antithrombotic use, and clinical outcomes of patients with atrial fibrillation (AF) and a thrombo-embolic event in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) study to better inform the care of these high-risk patients. Method and results Thrombo-embolic events were defined as stroke (ischaemic or unknown cause) or systemic embolism (SE). Clinical outcomes were estimated using the Kaplan-Me... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - Antithrombotic therapy; Thrombo-embolic events; Atrial fibrillation; ACUTE ISCHEMIC-STROKE; WARFARIN; APIXABAN; ANTICOAGULATION; 317 Pharmacy; 3121 General medicine, internal medicine and other clinical medicine; 3126 Surgery, anesthesiology, intensive care, radiology 
N1  -   
PP  -  
ER  -